Aclaris Therapeutics (ACRS) EPS (2015 - 2026)
Aclaris Therapeutics (ACRS) EPS from Mar 31, 2015 to Mar 31, 2026. The TTM Aclaris Therapeutics (ACRS) EPS is -$0.58. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Aclaris Therapeutics (ACRS) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -54.93% |
| 3 Years TTM | -26.01% |
| 5 Years TTM | -15.62% |
| 10 Years TTM | -14.97% |
| All Time TTM | -14.97% |
Annual EPS change of Aclaris Therapeutics (ACRS)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.14 | -73.66% |
| 2025 | -$0.54 | -56.00% |
| 2024 | -$1.22 | -1.89% |
| 2023 | -$1.25 | -4.23% |
| 2022 | -$1.30 | -12.18% |
| 2021 | -$1.48 | +31.23% |
| 2020 | -$1.13 | -70.93% |
| 2019 | -$3.89 | +20.75% |
| 2018 | -$3.22 | +45.05% |
| 2017 | -$2.22 | +20.36% |
| 2016 | -$1.85 | +80.89% |
| 2015 | -$1.02 | N/A |
Comparison Aclaris Therapeutics (ACRS) five years EPS CAGR with competitors
Aclaris Therapeutics (ACRS) five years EPS CAGR is -15.62%.